Evidence map›Paper›PMID 33192740›Full record

ArticleFrontiers in psychiatry2020

Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others-A Perspective of German Addiction Medicine Experts.

Udo Bonnet, Michael Specka, Michael Soyka, Thomas Alberti, Stefan Bender, Torsten Grigoleit, Leopold Hermle, Jörg Hilger, Thomas Hillemacher, Thomas Kuhlmann and 11 more

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Udo BonnetDepartment of Psychiatry, Psychotherapy and Psychosomatic Medicine, Evangelisches Krankenhaus Castrop-Rauxel, Academic Teaching Hospital of the University of Duisburg/Essen, Castrop-Rauxel, Germany.
Michael SpeckaDepartment of Psychiatry and Psychotherapy, Faculty of Medicine, Landschaftsverband Rheinland-Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Michael SoykaDepartment of Psychiatry and Psychotherapy University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
Thomas AlbertiDepartment of Psychiatry, Psychotherapy and Psychosomatic, Johanniter Hospital Oberhausen, Oberhausen, Germany.
Stefan BenderPsychiatry, Psychotherapy and Psychosomatics, Landschaftsverband Westfalen-Lippe-Hospital Marsberg, Marsberg, Germany.
Torsten GrigoleitPsychiatry and Psychotherapy, Landschaftsverband Rheinland-Hospital Langenfeld, Langenfeld, Germany.
Leopold HermleClinic for Psychiatry and Psychotherapy, Christophsbad, Göppingen, Germany.
Jörg HilgerClinic for Psychiatry, Psychotherapy, Psychosomatics and Neurology, Evangelische Stiftung Tannenhof, Remscheid, Germany.
Thomas HillemacherDepartment of Psychiatry, Socialpsychiatry and Psychotherapy, Hannover Medical School, Hanover, Germany.
Thomas KuhlmannClinic for Psychosomatics Bergisch-Gladbach, Bergisch Gladbach, Germany.
Jens KuhnDepartment of Psychiatry, Psychotherapy and Psychosomatic, Johanniter Hospital Oberhausen, Oberhausen, Germany.
Christian LuckhausDivision of Cognitive Neuropsychiatry and Psychiatric Preventive Medicine, Department of Psychiatry, Landschaftsverband Westfalen-Lippe University Hospital Bochum, Ruhr University Bochum, Bochum, Germany.
Christel LüdeckeLower Saxonian Psychiatric Hospital, Asklepios Hospital, Göttingen, Germany.
Jens ReimerCenter for Interdisciplinary Addiction Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Udo SchneiderDepartment of Psychiatry and Psychotherapy, Ruhr-University Bochum, Campus Ostwestfalen-Lippe, Luebbecke, Germany.
Welf SchroederMEDIAN Clinics Wied, Wied, Germany.
Markus StuppeDepartment of Addiction Medicine, Helios Medical Center Schwerin, Carl-Friedrich-Flemming-Clinic, Schwerin, Germany.
Gerhard A WiesbeckPsychiatric Hospital, University of Basel, Basel, Switzerland.
Norbert WodarzDepartment of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.
Heath McAnallyNorthern Anesthesia & Pain Medicine, Limited Liability Company, Eagle River, AK, United States.
Norbert ScherbaumDepartment of Psychiatry and Psychotherapy, Faculty of Medicine, Landschaftsverband Rheinland-Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alcoholgabapentinoidsillicit abused substancenew psychoactive drugspsychoropic drugs use

Identifiers

PMID33192740
PMCPMC7649209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.